Protalix BioTherapeutics (PLX) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 650.66% |
| Dec 31, 2025 | 168.46% |
| Sep 30, 2025 | 23.69% |
| Jun 30, 2025 | -1.06% |
| Mar 31, 2025 | -219.39% |
| Dec 31, 2024 | 36.36% |
| Sep 30, 2024 | 207.53% |
| Jun 30, 2024 | -187.27% |
| Mar 31, 2024 | 11.01% |
| Dec 31, 2023 | 148.35% |
| Sep 30, 2023 | -240.26% |
| Jun 30, 2023 | 246.92% |
| Mar 31, 2023 | -27.34% |
| Dec 31, 2022 | 72.67% |
| Sep 30, 2022 | -29.41% |
| Jun 30, 2022 | -18.98% |
| Mar 31, 2022 | -9.45% |
| Dec 31, 2021 | -148.88% |
| Sep 30, 2021 | -135.67% |
| Jun 30, 2021 | 161.01% |
| Mar 31, 2021 | -36.50% |
| Dec 31, 2020 | -102.02% |
| Sep 30, 2020 | 53.95% |
| Jun 30, 2020 | -12.03% |
| Mar 31, 2020 | -125.46% |
| Dec 31, 2019 | 11.92% |
| Sep 30, 2019 | 30.54% |
| Jun 30, 2019 | 30.07% |
| Mar 31, 2019 | -99.57% |
| Dec 31, 2018 | -127.57% |
| Sep 30, 2018 | 266.91% |
| Jun 30, 2018 | 16.07% |
| Mar 31, 2018 | -155.48% |
| Dec 31, 2017 | 261.36% |
| Sep 30, 2017 | -22.37% |
| Jun 30, 2017 | -0.59% |
| Mar 31, 2017 | -17.44% |
| Dec 31, 2016 | -108.02% |
| Sep 30, 2016 | 70.99% |
| Jun 30, 2016 | -29.98% |
| Mar 31, 2016 | -78.03% |
| Dec 31, 2015 | 46.71% |
| Sep 30, 2015 | -118.75% |
| Jun 30, 2015 | 26.80% |
| Mar 31, 2014 | -608.45% |
| Dec 31, 2013 | 119.81% |
| Sep 30, 2013 | 3.01% |
| Jun 30, 2013 | 13.88% |
| Mar 31, 2013 | -751.46% |
| Dec 31, 2012 | 117.84% |
| Sep 30, 2012 | -168.28% |
| Jun 30, 2012 | 281.74% |
| Mar 31, 2012 | 3.08% |
| Dec 31, 2011 | 19.89% |
| Sep 30, 2011 | -46.46% |
| Jun 30, 2011 | 5.42% |
| Mar 31, 2011 | 27.32% |
| Dec 31, 2010 | 17.72% |